October 2025
1. KORCHIA T, Palaniyappan L
   Sexual reactivation under aripiprazole in schizophrenia: a note for prescribers.
   J Psychiatry Neurosci. 2025;50:E334-E336.
   

   >> Share

   
   
2. MARQUES D, Spindola L, Narang A, Vaziri N, et al
   Differential DNA methylation and gene expression in stem cell-derived cardiomyocytes from patients with and without a history of clozapine-induced myocarditis.
   J Psychiatry Neurosci. 2025;50:E323-E333.
   

   >> Share

   
   July 2025
3. FABIANO N, Zhou C, Wong S, Correll CU, et al
   Switching to a muscarinic agonist to alleviate antipsychotic-induced metabolic and neuromotor adverse effects in a person living with schizophrenia.
   J Psychiatry Neurosci. 2025;50:E200-E201.
   

   >> Share

   
   
4. MASON AJC, Harada-Laszlo M, Wanduragala M, Tang R, et al
   Childhood trauma and hippocampal-dependent memory across the psychosis spectrum: a systematic review and meta-analysis.
   J Psychiatry Neurosci. 2025;50:E277-E298.
   

   >> Share

   
   January 2025
5. DJIMBOUON F, Klar P, Northoff G
   Shorter and inflexible intrinsic neural timescales of the self in schizophrenia.
   J Psychiatry Neurosci. 2025;50:E57-E66.
   

   >> Share

   
   November 2024
6. FAN L, Zhang Z, Ma X, Liang L, et al
   Glutamate levels and symptom burden in high-risk and first-episode schizophrenia: a dual-voxel study of the anterior cingulate cortex.
   J Psychiatry Neurosci. 2024;49:E367-E376.
   

   >> Share

   
   
7. WANG P, Jiang L, Hu J, Jiang Z, et al
   The amino acid metabolism pathway of peripheral T lymphocytes and ketamine-induced schizophrenia-like phenotype.
   J Psychiatry Neurosci. 2024;49:E413-E426.
   

   >> Share

   
   July 2024
8. ALONSO-SANCHEZ MF, Hinzen W, He R, Gati J, et al
   Perplexity of utterances in untreated first-episode psychosis: an ultra-high field MRI dynamic causal modelling study of the semantic network.
   J Psychiatry Neurosci. 2024;49:E252-E262.
   

   >> Share

   
   
9. WANG Z, Wu T, Hu H, Alabed AAA, et al
   Plasma exosomes carrying mmu-miR-146a-5p and Notch signalling pathway-mediated synaptic activity in schizophrenia.
   J Psychiatry Neurosci. 2024;49:E265-E281.
   

   >> Share

   
   January 2024
10. SUN Y, Bo Q, Mao Z, Tian Q, et al
    Different levels of prepulse inhibition among patients with first-episode schizophrenia, bipolar disorder and major depressive disorder.
    J Psychiatry Neurosci. 2024;49:E1-E10.
    

    >> Share

    
    
11. MARTINEZ-PEULA O, Morentin B, Callado LF, Meana JJ, et al
    Permissive epigenetic regulatory mechanisms at the histone level are enhanced in postmortem dorsolateral prefrontal cortex of individuals with schizophrenia.
    J Psychiatry Neurosci. 2024;49:E35-E44.
    

    >> Share

    
    
12. TANG Y, Tan Y, Palaniyappan L, Yao Y, et al
    Epigenetic profile of the immune system associated with symptom severity and treatment response in schizophrenia.
    J Psychiatry Neurosci. 2024;49:E45-E58.
    

    >> Share

    
    
13. TUPPURAINEN H, Maatta S, Kononen M, Julkunen P, et al
    Navigated and individual alpha-peak-frequency-guided transcranial magnetic stimulation in male patients with treatment-refractory schizophrenia.
    J Psychiatry Neurosci. 2024;49:E87-E95.
    

    >> Share

    
    
14. FOREMAN D
    Lessons from studies of medication reduction in psychosis: giving participants accurate information about risk in psychiatric research trials.
    J Psychiatry Neurosci. 2024;49:E81-E86.
    

    >> Share

    
    
15. PERROTTELLI A, Marzocchi FF, Caporusso E, Giordano GM, et al
    Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models.
    J Psychiatry Neurosci. 2024;49:E109-E125.
    

    >> Share

    
    
16. MIHALJEVIC M, Nagpal A, Etyemez S, Narita Z, et al
    Neuroimaging alterations and relapse in early-stage psychosis.
    J Psychiatry Neurosci. 2024;49:E135-E142.
    

    >> Share

    
    
17. DALTON K, Joober R, Karama S, Palaniyappan L, et al
    Making use of N-of-1 trials to treat ADHD in people with psychosis: a hypothetical case.
    J Psychiatry Neurosci. 2024;49:E133-E134.
    

    >> Share

    
    
18. 
    Correction to "Improving causality perception judgments in schizophrenia spectrum disorder via transcranial direct current stimulation".
    J Psychiatry Neurosci. 2024;49:E144.
    

    >> Share

    
    
19. 
    Correction to "Navigated and individual alpha-peak-frequency-guided transcranial magnetic stimulation in male patients with treatment-refractory schizophrenia".
    J Psychiatry Neurosci. 2024;49:E143.
    

    >> Share

    
    November 2023
20. CHOE E, Ha M, Choi S, Park S, et al
    Beyond verbal fluency in the verbal fluency task: semantic clustering as a predictor of remission in individuals at clinical high risk for psychosis.
    J Psychiatry Neurosci. 2023;48:E414-E420.
    

    >> Share

    
    
21. LIU S, Zhong H, Qian Y, Cai H, et al
    Neural mechanism underlying the beneficial effect of Theory of Mind psychotherapy on early-onset schizophrenia: a randomized controlled trial.
    J Psychiatry Neurosci. 2023;48:E421-E430.
    

    >> Share

    
    
22. HE K, Hua Q, Li Q, Zhang Y, et al
    Abnormal interhemispheric functional cooperation in schizophrenia follows the neurotransmitter profiles.
    J Psychiatry Neurosci. 2023;48:E452-E460.
    

    >> Share

    
    
23. SUN S, Xiao S, Guo Z, Gong J, et al
    Meta-analysis of cortical thickness reduction in adult schizophrenia.
    J Psychiatry Neurosci. 2023;48:E461-E470.
    

    >> Share

    
    September 2023
24. QUARTO T, Lella A, Di Carlo P, Rampino A, et al
    Heritability of amygdala reactivity to angry faces and its replicable association with the schizophrenia risk locus of miR-137.
    J Psychiatry Neurosci. 2023;48:E357-E366.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share